Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.360
-0.140 (-4.00%)
At close: Mar 9, 2026, 4:00 PM EDT
3.340
-0.020 (-0.60%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Quantum BioPharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
12.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQNTM News
- 2 months ago - Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) - GlobeNewsWire
- 3 months ago - Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update - Newsfile Corp
- 3 months ago - Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC - GlobeNewsWire
- 3 months ago - Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 - GlobeNewsWire
- 4 months ago - Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio - GlobeNewsWire
- 4 months ago - Quantum BioPharma Ltd. Provides Corporate Update - GlobeNewsWire
- 4 months ago - Quantum BioPharma Ltd. Announces Corporate Updates - Newsfile Corp
- 4 months ago - Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication - GlobeNewsWire